Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Case Report: Manic Decompensation During the Second Trimester of Pregnancy Requiring Electroconvulsive Therapy.

Created on 18 Nov 2026

Authors

Alicia López Toledo, Diego Rafael Jiménez Morón, Carlos Bonelli Franco, Adriana Junquera Blanco, Pablo Albarracín Marcos, Javier Jalvo Rogel, María de Las Nieves De Uribe Viloria, Francisco Montañés Rada, Pablo Martinez Rodriguez, Patricia Serrano De la Fuente, Beatriz Pulido Arnanz, Marcos Moreno Argenta, Cristina Corredera Pardo

Published in

The journal of ECT. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Manic episodes during pregnancy represent a significant clinical challenge due to risks for both the mother and fetus, as well as the limitations inherent to pharmacological treatment during gestation. Severe affective episodes-particularly those with manic symptoms-may lead to heightened maternal stress, impulsive behaviors, impaired self-care, and potential obstetric complications. Electroconvulsive therapy (ECT) constitutes a therapeutic alternative when pharmacotherapy is ineffective or contraindicated. We present the case of a 31-year-old pregnant woman with a history of an unspecified affective disorder within the bipolar spectrum, who developed an acute manic episode during the second trimester following withdrawal of lithium for conception planning. The patient required psychiatric hospitalization due to progressive psychomotor agitation, disinhibition, and insomnia. After multidisciplinary evaluation, nine ECT sessions were administered between 18 and 21 weeks of gestation, with standardized anesthetic management and close obstetric monitoring. No maternal or fetal complications were observed. The patient exhibited progressive clinical improvement, allowing stabilization and safe continuation of pregnancy. This case highlights the potential efficacy and relative safety of ECT in managing severe manic episodes during pregnancy when prompt maternal stabilization is required. It also underscores the importance of coordinated multidisciplinary care and individualized risk-benefit assessment.

PMID:
43044039
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement